Indivior Pharmaceuticals Inc. (INDV) Tops Q4 Earnings and Revenue Estimates
Indivior Pharmaceuticals Inc. (INDV) delivered earnings and revenue surprises of +26.80% and +17.15%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?